## **Core Concept**
Congenital CMV infection is diagnosed in a neonate based on the presence of specific virological, clinical, and laboratory findings. The diagnosis can be established by isolating the virus from urine or saliva within the first two weeks of life or by detecting CMV-specific IgM antibodies in the neonate's blood.

## **Why the Correct Answer is Right**
The correct answer, **D.**, implies that the option does not contribute to establishing a diagnosis of active congenital CMV infection. Typically, the presence of CMV IgG antibodies in the neonate's blood indicates passive transfer from the mother and does not distinguish between congenital and postnatally acquired infection. Therefore, detecting only CMV IgG antibodies without evidence of IgM antibodies or viral isolation does not confirm active congenital infection.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option likely represents a scenario where CMV is isolated from urine or another bodily fluid within the first two weeks of life, which is a definitive indicator of congenital CMV infection.
- **Option B:** This option probably indicates the detection of CMV-specific IgM antibodies in the neonate, which suggests a congenital infection since IgM antibodies do not cross the placenta.
- **Option C:** This option might signify the presence of clinical manifestations or laboratory findings consistent with congenital CMV infection, such as petechiae, hepatosplenomegaly, or abnormal neuroimaging.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the detection of **CMV IgM antibodies** in a neonate is a critical diagnostic criterion for congenital CMV infection. Additionally, **viral isolation from urine or saliva** within the first two weeks of life is also diagnostic. It's crucial to differentiate between congenital and postnatally acquired CMV infection, as the former is associated with more severe outcomes.

## **Correct Answer:** D. Detection of CMV IgG antibodies.